Growth ProspectsThe company reiterated its expectations on quarterly new account adds, utilization increases, and sequential sales growth cadence throughout the remainder of 2025.
Reimbursement PotentialThe next catalyst for CVRX will be the July reimbursement proposal for CMS, potentially creating a permanent outpatient category which could remove part of the multi-year overhang on the stock.
Salesforce ImprovementManagement is thrilled with the experience of new reps onboarding, the majority of whom have experience in therapy development, stakeholder relationships from their prior company, and an understanding of cardiac medicine.